Purpose
Therapeutic Drug Monitoring
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80346
New York State Approval Status

Approved

Turnaround Time

5 days

Test Includes
1 Clonazepam Klonopin® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2 Anticonvulsant, Antiepileptic
2 7-Amino Clonazepam Clonazepam Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2 Hypnotic, Sedative

Test Also Known As
Rivotril®
Specimen Type
Urine
Requested Volume
2 mL
Minimum Volume
0.7 mL
Special Handling
None
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Received Frozen.

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 14 day(s)
Refrigerated: 14 day(s)
Frozen (-20 °C): Not Stable
1 Clonazepam Klonopin® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2 Anticonvulsant, Antiepileptic
2 7-Amino Clonazepam Clonazepam Metabolite High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) ng/mL 2 Hypnotic, Sedative

Interface Map

LOINC® Information